Hemetron
Zürich, Switzerland
Hemetron enables quantitative at-home blood testing and remote monitoring for chronic diseases, starting with rheumatology. We empower physicians to personalize treatment using accurate, quantitative self-tests, beginning with CRP for inflammatory conditions. Our platform brings lab-grade biomarker insights into patients’ homes, closing monitoring gaps that delay care and drive up costs. Backed by leading clinicians, the Innosuisse Start-up Innovation Project grant and selected as a Venture Leader Medtech 2025, Hemetron is shaping the future of precision care, starting at home.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- www.hemetron.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Hemetron?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now